可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Faber TS, Zehender M, Krahnefeld O,et al. Propafenone during acute myocardial ischemia in patients: a double-blind, randomized, placebo-controlled study [J].J Am Coll Cardiol,1997, 29(3): 561-567.
[2] Mastropasqua F, Totaro P, Massari F,et al. Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms[J].Cardiologia, 1998, 43(6): 617
-623.
[3] Koller B, Franz MR. New classification of moricizine and propafenone based on electrophysiologic and electrocardiographic data from isolated rabbit heart [J].J Cardiovasc Pharmacol, 1994, 24(5): 753-760.
[4] Takahashi N, Ito M, Ishida S,et al. Electrophysiological effects of SD-3212, a novel antiarrhythmic agent, on rabbit hearts in vivoandin vitro[J].J Cardiovasc Pharmacol, 1995, 25(6): 1006-1011.
[5] Yin H, Sherif N, Caref EB,et al. Actions of lidocaine on reentrant ventricular rhythms in the subacute myocardial infarction period in dogs[J].Am J Physiol, 1997, 272(1 Pt 2): H299-H300.
[6] Bardou AL, Auger PM, Achour S,et al. Effect of myocardial infarction and ischemia on induction of cardiac reentries and ventricular fibrillation[J].Acta Biotheor, 1995,43(4): 363-372.